Compass Therapeutics's market cap is currently $598.79M. The company's EPS TTM is $-0.14; its P/E ratio is ―; Compass Therapeutics is scheduled to report earnings on August 11, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
